Skip to main content
. 2015 Feb 24;290(17):10840–10849. doi: 10.1074/jbc.M115.636878

FIGURE 6.

FIGURE 6.

Formoterol treatment increases energy expenditure in SlnOE but not in Sln−/− mice. A and B, oxygen consumption before and after treatment with formoterol, a β2-adrenergic receptor-selective agonist (n = 8). C, percentage change in fatty acid utilization after formoterol administration. *, p = 0.05; **, p < 0.01; ns, not significant.